Found 4 matching trials
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
PHASE3The purpose of this study is to compare progression-free survival (PFS) (ba...
Location
Multiple Locations
Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04)
PHASE2The objective of this study is to compare progression-free survival (PFS), ...
Location
Multiple Locations
Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, EC-FV-01)
PHASE1This is a Phase I clinical trial evaluating the safety and tolerability of ...
Location
Greenebaum Cancer Center at University of Maryland Medical Center
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
PHASE2This study will test the activity of single-agent EC145 and the combination...
Location
Multiple Locations